Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer D Stone

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Methods in Enzymology|January 11, 2012
T cell receptor engineeringJennifer D Stone, Adam S Chervin, David H Aggen, et al.
Oncoimmunology|November 20, 2012
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)Jennifer D Stone, David H Aggen, Andrea Schietinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientationLindsay L Jones, Leremy A Colf, Jennifer D Stone, et al.
Plos One|August 26, 2015
A Multiplex Assay for Detection of Staphylococcal and Streptococcal ExotoxinsPreeti Sharma, Ningyan Wang, Adam S Chervin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2011
Interaction of streptavidin-based peptide-MHC oligomers (tetramers) with cell-surface TCRsJennifer D Stone, Maxim N Artyomov, Adam S Chervin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2009
The impact of TCR-binding properties and antigen presentation format on T cell responsivenessAdam S Chervin, Jennifer D Stone, Phillip D Holler, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2012
MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCRCarolina M Soto, Jennifer D Stone, Adam S Chervin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2011
Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8Jennifer D Stone, David H Aggen, Adam S Chervin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC moleculesQing Ge, Jennifer D Stone, M Todd Thompson, et al.
Cancer Immunology, Immunotherapy : CII|August 2, 2014
A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor controlJennifer D Stone, Daniel T Harris, Carolina M Soto, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Methods in Enzymology|January 11, 2012
T cell receptor engineeringJennifer D Stone, Adam S Chervin, David H Aggen, et al.
Oncoimmunology|November 20, 2012
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)Jennifer D Stone, David H Aggen, Andrea Schietinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientationLindsay L Jones, Leremy A Colf, Jennifer D Stone, et al.
Plos One|August 26, 2015
A Multiplex Assay for Detection of Staphylococcal and Streptococcal ExotoxinsPreeti Sharma, Ningyan Wang, Adam S Chervin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2011
Interaction of streptavidin-based peptide-MHC oligomers (tetramers) with cell-surface TCRsJennifer D Stone, Maxim N Artyomov, Adam S Chervin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2009
The impact of TCR-binding properties and antigen presentation format on T cell responsivenessAdam S Chervin, Jennifer D Stone, Phillip D Holler, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2012
MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCRCarolina M Soto, Jennifer D Stone, Adam S Chervin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2011
Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8Jennifer D Stone, David H Aggen, Adam S Chervin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC moleculesQing Ge, Jennifer D Stone, M Todd Thompson, et al.
Cancer Immunology, Immunotherapy : CII|August 2, 2014
A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor controlJennifer D Stone, Daniel T Harris, Carolina M Soto, et al.
Pageof 3